We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$1.9M
Cap. Flow
-$30.9M
Cap. Flow %
-9.55%
Top 10 Hldgs %
61.81%
Holding
89
New
17
Increased
17
Reduced
13
Closed
9

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$6.97M
2
ORIC icon
Oric Pharmaceuticals
ORIC
+$5.93M
3
MPLT
MapLight Therapeutics
MPLT
+$5.48M
4
PAYO icon
Payoneer
PAYO
+$4.81M
5
LENZ
LENZ Therapeutics
LENZ
+$4.37M

Top Sells

Rank Stock Value
1
EVCM icon
EverCommerce
EVCM
+$18.3M
2
ROIV icon
Roivant Sciences
ROIV
+$14.3M
3
NCDL icon
Nuveen Churchill Direct Lending
NCDL
+$13.5M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.9M
5
IRON icon
Disc Medicine
IRON
+$6.76M

Sector Composition

Rank Sector Weight
1 Healthcare 63.81%
2 Financials 18.18%
3 Technology 8.81%
4 Consumer Discretionary 7.9%
5 Energy 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENGNW icon
51
enGene Therapeutics Warrants
ENGNW
$103K 0.03%
36,100
– –
AMODW
52
Alpha Modus Holdings Warrant
AMODW
$316K
$92.7K 0.03%
1,854,665
– –
SHFS icon
53
SHF Holdings
SHFS
$1.13M
$80.5K 0.02%
75,897
– –
SLND.WS icon
54
Southland Holdings Warrants
SLND.WS
$77.4K 0.02%
860,302
– –
BGLWW
55
Blue Gold Ltd Warrant
BGLWW
$736K
$77K 0.02%
175,000
– –
RDZNW icon
56
Roadzen Inc Warrants
RDZNW
$8.64M
$60.8K 0.02%
225,000
– –
AEON icon
57
AEON Biopharma
AEON
$13.5M
$47.7K 0.01%
43,395
+1,042
+2% +$973
ANGX
58
Angel Studios
ANGX
$801M
$46.7K 0.01%
+10,000
New +$59.3K
LVWR.WS icon
59
LiveWire Group Warrants
LVWR.WS
$5.09M
$30K 0.01%
500,000
+100,000
+25% +$8.89K
DAVEW icon
60
Dave Inc Warrants
DAVEW
$15.1M
$28.2K 0.01%
28,750
– –
DAICW
61
CID HoldCo Inc Warrants
DAICW
$78.4K
$24K 0.01%
300,000
– –
BKSY.WS icon
62
BlackSky Technology Inc Warrants
BKSY.WS
$65.9K
$17.5K 0.01%
350,000
– –
PGYWW
63
Pagaya Technologies Ltd Warrants
PGYWW
$1.38M
$15.6K ﹤0.01%
48,661
– –
NVNIW
64
Nvni Group Limited Warrants
NVNIW
$836K
$14K ﹤0.01%
200,000
– –
ZEOWW
65
Zeo Energy Corp Warrants
ZEOWW
$10K ﹤0.01%
250,000
– –
TVGNW icon
66
Tevogen Inc. Warrant
TVGNW
$976K
$8K ﹤0.01%
200,000
– –
BTMWW
67
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$5.5K ﹤0.01%
50,000
– –
BAERW icon
68
Bridger Aerospace Warrant
BAERW
$8.48M
$5K ﹤0.01%
+25,000
New +$3.04K
BDMDW
69
Baird Medical Investment Holdings Warrant
BDMDW
$5K ﹤0.01%
100,000
– –
BSLKW
70
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$3.33K ﹤0.01%
166,666
– –
SDSTW
71
Stardust Power Inc Warrant
SDSTW
$5.67M
$2.53K ﹤0.01%
31,666
+15,000
+90% +$2.22K
PDYNW icon
72
Palladyne AI Corp Warrants
PDYNW
$156K
$2.1K ﹤0.01%
+35,000
New +$5.09K
LIMNW
73
Liminatus Pharma Warrants
LIMNW
$2K ﹤0.01%
50,000
– –
WALDW icon
74
Waldencast PLC Warrant
WALDW
$4.21M
$1.33K ﹤0.01%
33,333
– –
ASBPW
75
Aspire Biopharma Warrant
ASBPW
$1K ﹤0.01%
50,000
– –
1 2
3
4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q4 2025 Portfolio in Review

As of Q4 2025, Blue Owl Capital Holdings held 89 positions worth $324M, up 0.59% from $322M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Blue Owl Capital Holdings withdrew a net $30.9M in Q4 2025, closing 9 positions and reducing 13 holdings. Its most notable exit was EverCommerce, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 57% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Procore worth $6.86M.

  • Blue Owl Capital Holdings's largest Q4 2025 buy was Procore: 94,264 shares worth $6.86M.
  • Blue Owl Capital Holdings added most to Compass Therapeutics in Q4 2025, an estimated $4.04M increase.
  • Blue Owl Capital Holdings's biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $14.3M.
  • Blue Owl Capital Holdings fully exited EverCommerce in Q4 2025, selling an estimated $18.3M.
  • Blue Owl Capital Holdings's ten largest holdings make up 62% of its $324M portfolio in Q4 2025.
  • Blue Owl Capital Holdings opened 17 new positions and closed 9 in Q4 2025.
  • Blue Owl Capital Holdings's portfolio value rose 0.59% quarter-over-quarter to $324M.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.